| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6473bc00ea45e83424df133e1c1b7b0b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-125 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078 |
| filingDate |
2002-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29838fc0d94d5578bf61785c50b251ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee3ef580a9739556fa69fd4d4721cedd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1b0cfc950b22c412b1b1aa1685d2184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f030912e2d6d80873a7d0a4145c4613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f914f0cd132bfbd00c09e2c0d1a5bdb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a89bf7e67bf06b0e1a62fc7a9c9adc8 |
| publicationDate |
2003-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1336846-A1 |
| titleOfInvention |
Method for generating recombinant human platelets for identifying therapeutic target proteins |
| abstract |
A composition is provided comprising platelets having a combination of the following modifications: (a) a modification of the protein constituents of the platelets which is obtained or obtainable by genetic modification of platelet precursor cells; (b) incorporation of a detectable label into said platelet; whereby the functions of modification (a) and (b) are mutually independent. Further, methods of determining platelet functions, notably aggregation and adhesion to endothelial cells are provided. Further, a novel method of preparing transgenic or modified platelets is provided. |
| priorityDate |
2002-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |